Within the interim analysis, Xofigo significantly improved overall survival (OS) [HR=0.695 (95% CI 0.552 0.875), p=0.00185]; median OS was 14.0 months with Xofigo plus best standard of care (95% CI 12.1, 15.8) vs. 11.2 months with placebo plus best standard of care (95% CI 9.0, 13.2).1 Additionally, with the interim analysis there seemed to be a delay at some point to first symptomatic skeletal event (SSE) for patients given Xofigo vs. Placebo.
This definitely provides benefit but has unwanted effects just like sedation, dry mouth, blurry or double vision. Maintaining hydration stops nausea. Sometimes, many different reasons, this isn't a possibility, however.. Left for church and Sunday School in the First Presbyterian Church, the place that the slaves were ready to sit inside gallery. I remember that Dr. Hoyt helpful to pray the fact that Lord would drive the Yankees back.
